CN103110719B - Traditional Chinese medicine wine for treating kidney deficiency and essence depletion type osteoporosis - Google Patents
Traditional Chinese medicine wine for treating kidney deficiency and essence depletion type osteoporosis Download PDFInfo
- Publication number
- CN103110719B CN103110719B CN201210529366.9A CN201210529366A CN103110719B CN 103110719 B CN103110719 B CN 103110719B CN 201210529366 A CN201210529366 A CN 201210529366A CN 103110719 B CN103110719 B CN 103110719B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- essence
- deficiency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention discloses a traditional Chinese medicine wine for treating kidney deficiency and essence depletion type osteoporosis, belonging to the field of traditional Chinese medicine and pharmacy. The traditional Chinese medicine comprises the following raw materials in parts by weight: 5 parts of morinda root, 3 parts of Scurfpea fruit, 5 parts of broomrape, 3 parts of radix salviae miltiorrhizae, 3 parts of radix astragali, 5 parts of walnut kernel, 3 parts of spatholobus stem, 3 parts of mulberry fruit, 5 parts of black sesame seed and 2 parts of Trachelospermum jasminoides. The traditional Chinese medicine wine disclosed by the invention is developed through clinical practice on the basis of diagnosis and treatment based on an overall analysis of the illness and the patient's condition according to traditional Chinese medicine, has the effects of tonifying liver and kidneys and strengthening bones and muscles, and has the characteristics of exact treatment effect, quick effect taking, high safety and convenience and no toxic or side effect.
Description
Technical field
The invention belongs to Chinese medicine field, relate to a kind of osteoporotic Chinese medicine tincture of deficiency of kidney essence type for the treatment of.
Background technology
Deficiency of kidney essence type osteoporosis is frequently-occurring disease, the commonly encountered diseases of mid-aged population, and it occurs how by hypendocrisia, gonadal hormone minimizing and potein deficiency, to be caused bone cell function reduction and bone field cell to form minimizing and to be caused bone trabecular attenuation or the change of bone pine.The traditional Chinese medical science thinks that primary disease belongs to Chinese medicine " atrophic debility of bones " category, and how because deficiency of kidney essence, kidney yang deficiency can not fill the raw marrow of bone, deficiency of kidney yin, essence are become homeless foster, can not support marrow.Clinically show as onset slowly, limbs flaccidity is soft unable, limitation pain, hunchback, soreness of the waist and knees, can not standing for a long time, has a dizzy spell, tinnitus, man's seminal emission, sexual impotence, amyotrophy, the symptoms such as lassitude.The main pathogenesis of primary disease is that the mistakes of caused by liver and kidney deficiency, muscles and bones are supported.By dialectical, taking invigorating the liver and kidney, bone and muscle strengthening is principle for the treatment of, has obtained good therapeutic effect clinically.
Summary of the invention
The object of this invention is to provide a kind of osteoporotic Chinese medicine tincture of deficiency of kidney essence type for the treatment of, the feature that there is determined curative effect, instant effect, safe ready, has no side effect.
The present invention treats the osteoporotic Chinese medicine tincture of deficiency of kidney essence type, it is characterized in that, the weight of raw material of Chinese medicine consists of: 2 parts of 5 parts of Radix Morindae Officinaliss, 3 parts of Fructus Psoraleaes, 5 parts of Herba Cistanches, 3 parts of Radix Salviae Miltiorrhizaes, 3 parts of the Radixs Astragali, 5 parts of Semen Juglandis, 3 parts of Caulis Spatholobis, 3 parts of Fructus Mori, 5 parts of Semen Sesami Nigrums and Caulis Trachelospermis.
Preparation method: the medicine-feeding process of preparing Chinese medicine is qualified, weighing is assorted, and rolls altogether the coarser powder for 2--3.Medicamental pulverata is put into container, add 500 parts of 60 ° of Chinese liquor, sealing is soaked 90 days.Filter, immersion is removed slag, staticly settled, get supernatant and bottle and get final product.
Therapeutic scheme: oral wine, a 20ml, day takes secondary, and three months is a course for the treatment of, serve on two courses for the treatment of.
Drug action mechanism in the present invention is as follows:
Radix Morindae Officinalis: kidney-replenishing, bone and muscle strengthening, wind-damp dispelling, this product energy warming the kidney to invigorate YANG, benefit essence, be usually used in deficiency of the liver and kindey, muscles and bones flaccidity soft etc.
Fructus Psoraleae: kidney invigorating and YANG supporting, controlling nocturnal emission with astringent drugs reducing urination, warm spleen antidiarrheal, helping inspiration to relieve asthma, this product warming and recuperating the gate of life, replenishing kidney, strengthening waist, tonifying YANG, controlling nocturnal emission with astringent drugs, be usually used in yang deficiency and lower first void such as loses at the card.
Herba Cistanches: kidney-replenishing, benefiting essence-blood, loosening bowel to relieve constipation, this product energy kidney-replenishing, benefiting essence-blood, be usually used in treating insufficiency of kidney-YANG.
Radix Salviae Miltiorrhizae: promoting blood flow to regulate menstruation, removing heat from blood eliminating carbuncle, calm the nerves, the key medicine that this product is blood circulation promoting and blood stasis dispelling.
The Radix Astragali: tonifying Qi and lifting yang, benefit are defended consolidating superficial resistance, inducing diuresis to remove edema, promoting pus discharge and tissue regeneration strengthening.
Semen Juglandis: the kidney invigorating, warming the lung, intestine moistening, this product warming and recuperating the kidney-YANG, strong waist knee joint.
Caulis Spatholobi: blood circulation promoting and enriching, regulating menstruation, relaxing muscles and tendons and activating QI and blood in the collateral, this product can be invigorated blood circulation and can be enriched blood, and person is especially good for blood deficiency, to have blood stasis concurrently.
Fructus Mori: nourishing YIN and supplementing blood, promote the production of body fluid, intestine moistening, this product has the moon of nourishing the liver and kidney and the merit of enriching blood.
Semen Sesami Nigrum: invigorating the liver and kidney, benefiting essence-blood, intestine moistening are dry.
Caulis Trachelospermi: dispelling wind and removing obstruction in the collateral, removing heat from blood, detumescence.
The effect of all medicines and cure mainly and be all referred to higher learning of Chinese medicine undergraduate course teaching material sixth version < < Chinese materia medica > >, Science and Technology of Shanghai publishing house above.
Below for clinical trial is summed up:
The osteoporotic clinical symptoms of deficiency of kidney essence type is: onset is slowly, limbs flaccidity is soft unable, limitation pain, hunchback, and soreness of the waist and knees, can not standing for a long time, has a dizzy spell, tinnitus, man's seminal emission, sexual impotence, amyotrophy, lassitude etc.
Treatment standard:
Significant effective: symptom is significantly improved, X sheet checks that bone trabecula increases, and bone density increases, and uniformity decalcification is reversed.
Effective: primary symptom is improved, X sheet checks that bone trabecula increases, and bone density increases, and uniformity decalcification is not yet reversed.
Unchanged: cardinal symptom is slightly improved, after x-ray inspection treatment, osteocomma contrast is unchanged.
Therapeutic outcome: clinical trial treatment deficiency of kidney essence type sufferers of osteoporosis face 200 examples.Patient is through Drug therapy of the present invention after two courses for the treatment of, and significant effective 150 examples, account for 75%, and effective 40 examples, account for 20%, and unchanged 10 examples, account for 5%, total effective rate 95%.Shown in treatment, without any side effects to patient, three large routine tests and hepatic and renal function detect no abnormal.
Below enumerate several model cases:
Case 1: patient thanks so-and-so, man, 50 years old, because of limitation lumbar and back pain, companion is numb, while bending and stretching back, occur intercostal portion pain, unable for 3 years, X sheet checks Decrease of Bone Mineral Density, and bone trabecula reduces, attenuates, in May, 2011 Lai Zhenwo institute, examine as deficiency of kidney essence type osteoporosis, oral administration Drug therapy of the present invention is after two courses for the treatment of, and symptom is significantly improved, X sheet checks that bone trabecula increases, and bone density increases.Following up a case by regular visits to 1 year symptom does not increase the weight of.
Case 2: patient Chen, female, 60 years old, because of long-term soreness of the waist and knees, unable, and be limitation pain, limitation of activity, in June, 2011, Lai Zhenwo institute, examined as deficiency of kidney essence type osteoporosis, oral administration Drug therapy of the present invention is after two courses for the treatment of, symptom is significantly improved, and X sheet checks that bone trabecula increases, and bone density obviously increases.Following up a case by regular visits to 1 year symptom does not increase the weight of.
Case 3: patient king so-and-so, female, 66 years old, suffers from deficiency of kidney essence type osteoporosis more than 2 years, multi-treatment is invalid, in July, 2011 Lai Zhenwo institute, oral administration Drug therapy of the present invention is after two courses for the treatment of, symptom is significantly improved, and X sheet checks that bone trabecula increases, and bone density obviously increases.Following up a case by regular visits to 1 year symptom does not increase the weight of.
Compared with prior art, the present invention has following beneficial effect:
(1) the selected Chinese herbal medicine of the present invention all meets < < Pharmacopoeia of People's Republic of China > > regulation, and according to compatibility, the present invention has the effect of invigorating the liver and kidney, bone and muscle strengthening.
(2) the present invention develops in conjunction with clinical trial on the basis of traditional tcm treatment according to syndrome differentiation, not only deficiency of kidney essence type osteoporosis is had to good therapeutical effect, and primary disease is had to good preventive effect.
(3) the present invention is nontoxic, harmless, and prescription is rigorous, determined curative effect, and taking convenience, is easily accepted by patient.
The specific embodiment:
Below in conjunction with embodiment, the invention will be further described.
Embodiment
The weight of raw material of Chinese medicine consists of:
2 parts of 5 parts of Radix Morindae Officinaliss, 3 parts of Fructus Psoraleaes, 5 parts of Herba Cistanches, 3 parts of Radix Salviae Miltiorrhizaes, 3 parts of the Radixs Astragali, 5 parts of Semen Juglandis, 3 parts of Caulis Spatholobis, 3 parts of Fructus Mori, 5 parts of Semen Sesami Nigrums and Caulis Trachelospermis.
Preparation method: the medicine-feeding process of preparing Chinese medicine is qualified, weighing is assorted, and rolls altogether the coarser powder for 2--3.Medicamental pulverata is put into container, add 500 parts of 60 ° of Chinese liquor, sealing is soaked 90 days.Filter, immersion is removed slag, staticly settled, get supernatant and bottle and get final product.Cold drink clothes, a 20ml, a twice-daily, three months is a course for the treatment of.
Claims (1)
1. treat the osteoporotic Chinese medicine tincture of deficiency of kidney essence type for one kind, it is characterized in that, the weight of each raw material of Chinese medicine consists of: 2 parts of 5 parts of Radix Morindae Officinaliss, 3 parts of Fructus Psoraleaes, 5 parts of Herba Cistanches, 3 parts of Radix Salviae Miltiorrhizaes, 3 parts of the Radixs Astragali, 5 parts of Semen Juglandis, 3 parts of Caulis Spatholobis, 3 parts of Fructus Mori, 5 parts of Semen Sesami Nigrums and Caulis Trachelospermis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210529366.9A CN103110719B (en) | 2012-12-10 | 2012-12-10 | Traditional Chinese medicine wine for treating kidney deficiency and essence depletion type osteoporosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210529366.9A CN103110719B (en) | 2012-12-10 | 2012-12-10 | Traditional Chinese medicine wine for treating kidney deficiency and essence depletion type osteoporosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103110719A CN103110719A (en) | 2013-05-22 |
| CN103110719B true CN103110719B (en) | 2014-07-16 |
Family
ID=48409122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210529366.9A Expired - Fee Related CN103110719B (en) | 2012-12-10 | 2012-12-10 | Traditional Chinese medicine wine for treating kidney deficiency and essence depletion type osteoporosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103110719B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1899479A (en) * | 2006-07-05 | 2007-01-24 | 王悦 | Chinese medicine compound preparation for treating osteoporosis after menopause and its preparation |
-
2012
- 2012-12-10 CN CN201210529366.9A patent/CN103110719B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1899479A (en) * | 2006-07-05 | 2007-01-24 | 王悦 | Chinese medicine compound preparation for treating osteoporosis after menopause and its preparation |
Non-Patent Citations (4)
| Title |
|---|
| 《补肾中药改善骨质疏松症的实验研究近况》;孙河龙等;《中医学报》;20111001;第26卷(第10期);第1198－1200页 * |
| 《补肾益精法治疗骨质疏松症84例》;宋红湘;《陕西中医》;20031231;第24卷(第12期);第1075－1077页 * |
| 孙河龙等.《补肾中药改善骨质疏松症的实验研究近况》.《中医学报》.2011,第26卷(第10期),第1198－1200页. |
| 宋红湘.《补肾益精法治疗骨质疏松症84例》.《陕西中医》.2003,第24卷(第12期),第1075－1077页. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103110719A (en) | 2013-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101411802B (en) | Black plaster for treating hyperosteogeny and preparation method thereof | |
| CN101134083A (en) | Chinese medicinal herb capsule for treating diabetes and its complication and method for preparing the same | |
| CN102247497A (en) | Chinese patent medicine for treating rheumatoid arthritis | |
| CN101357168B (en) | Medicinal wine for treating rheumatic arthritis | |
| CN105362491A (en) | External-use medicine for treating cervical vertebra hyperosteogeny | |
| CN104758743A (en) | Traditional Chinese medicine foot fumigating powder for treating rheumatism as well as preparation method and using method thereof | |
| CN101721651B (en) | Traditional Chinese medicine capsule for treating scapulohumeral periarthritis | |
| CN102000238B (en) | Martianus dermestoides capsule and preparation method | |
| CN101912567B (en) | Chinese medicinal prescription for treating chronic myocarditis | |
| CN103721082B (en) | A kind of Chinese medicine composition of cure scapulohumeral periarthritis | |
| CN102949619A (en) | Traditional Chinese medicine composition for treating colitis | |
| CN104784614A (en) | Traditional Chinese medicine composition for treating kidney deficiency | |
| CN103212013B (en) | Chinese medicinal composition for treating epigastric pain | |
| CN101632831B (en) | Traditional Chinese medicine medicated wine for treating waist and leg pains | |
| CN102935214B (en) | Traditional Chinese medicinal composition for treating uremia | |
| CN103110719B (en) | Traditional Chinese medicine wine for treating kidney deficiency and essence depletion type osteoporosis | |
| CN105435210A (en) | Traditional Chinese medicine oriented permeable drug treatment liquid for treating cold-dampness stasis type lumbar disc herniation and preparation method thereof | |
| CN103099889B (en) | Traditional Chinese medicine wine for treating lumbar spinal stenosis | |
| CN101569708B (en) | Medicament for treating ischemic heart disease and preparation method thereof | |
| CN105125978A (en) | Traditional Chinese medicine preparation for treating rheumatic arthritis and preparation method thereof | |
| CN101125180A (en) | Traditional Chinese medicine for curing rheumatism | |
| CN104758888A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN104623506A (en) | Traditional Chinese medicine for treating infertility gynaecopathia | |
| CN104758889A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN104758539A (en) | Traditional Chinese medicine composition for treating debilitation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wang Xuezhen Inventor before: Song Aimin |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170608 Address after: 3, unit 28, building 417, 601 Yang Xing Road, Chengyang District, Shandong, Qingdao 266109, China Patentee after: Zhang Bingqiang Address before: 256100 Yiyuan people's Hospital, Zibo, Shandong, China Patentee before: Song Aimin |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140716 Termination date: 20171210 |